Puerarin preserves microglial homeostasis and protects against acute cerebral ischemia-reperfusion injury by regulating autophagy and oxidative stress through Janus kinase 2/signal transducer and activator of transcription 3.
Abstract
Background
Microglial oxidative stress and dysregulated autophagy contribute to secondary neuronal injury following ischemic stroke. Puerarin (PUE), a bioactive isoflavone with established antioxidative and neuroprotective properties, may protect against cerebral ischemia by modulating microglial dysfunction; however, the underlying mechanisms remain unclear.
Methods
The neuroprotective effects of PUE were investigated in a rat transient middle cerebral artery occlusion (tMCAO) model and in BV2 microglia subjected to oxygen-glucose deprivation/reoxygenation (OGD/R). Microglial phenotypic alterations, oxidative stress, and autophagic activity were evaluated using single-cell RNA sequencing (scRNA-seq), ultrastructural, biochemical, and fluorescence-based analyzes. Data-independent acquisition (DIA) proteomics, pharmacological gain- and loss-of-function approaches, and adeno-associated virus serotype 9 (AAV9)-mediated Janus kinase 2 (JAK2) knockdown were employed to define the role of Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling. Microglia-mediated neuroprotection was further assessed using an HT22 neuron-microglia co-culture system.
Results
PUE reshaped the microglial landscape by preserving the homeostatic microglial phenotype while suppressing ischemia-induced pathological activation. PUE reduced intracellular and mitochondrial ROS production, restored redox homeostasis, suppressed excessive autophagosome formation, and downregulated the autophagy-related proteins 3/5/12 (ATG3/5/12). Mechanistically, these protective effects were mediated through inhibition of JAK2/STAT3 signaling. Genetic silencing of JAK2 recapitulated the effects of PUE, whereas pharmacological activation of JAK2/STAT3 largely abolished its antioxidative, anti-autophagic, and neuroprotective activities. Furthermore, conditioned media from PUE-treated microglia significantly alleviated neuronal injury in HT22 cells, supporting a microglia-mediated paracrine mechanism of neuroprotection.
Conclusion
Collectively, these findings identify JAK2/STAT3-dependent regulation of the oxidative stress-autophagy axis as a critical mechanism underlying microglial homeostasis after acute cerebral ischemia-reperfusion injury (CIRI) and establish PUE as a promising therapeutic candidate for ischemic stroke.